Studying drug resistance using genetically engineered mouse models for breast cancer

Sven Rottenberg1, Marina Pajic, Jos Jonkers

  • 1Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. s.rottenberg@nki.nl

Summary

Genetically engineered mouse models (GEMMs) offer powerful tools to study breast cancer drug resistance. These models allow researchers to investigate resistance mechanisms in vivo with accessible tumors and modified cells.